VIVUS INC

1172 Castro St Ticker: VVUS
Mountain View , CA 94040-2552 Exchange: NASD
650-934-5200 Sector: Health Care
Industry: Pharmaceuticals

Complete Financials: Q3Y09 Currency: USD Current Annual Period: Y08
Business Summary
VVUS VIVUS, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for underserved markets in the United States. The company offers MUSE, a minimally invasive therapy for erectile dysfunction.


RATIOS AND STATISTICS AT A GLANCE
( As of 03/11/2010 )
Price

52 Week High

52 Week Low

3 Month Avg Daily Vol (Mil)

10 Day Avg Daily Vol (Mil)

Beta

Indicated Annual Dividend

Dividend Yield % 		9.370

12.880

2.720

2.750

2.253

0.898

0.000

0.000 		Price/Sales (TTM)

P/E Ratio (TTM)

Price/Book (MRQ)

Price/Cash Flow (TTM)

Return on Assets (TTM) %

Return on Equity (TTM) %

Current Ratio (MRQ)

Total Debt/Equity (MRQ) 		10.758

NC

3.401

3.326

-24.119

-33.472

10.469

0.102

Note:
Mil = Millions
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months


SHARE RELATED INFORMATION SHORT INTEREST INFORMATION
Market Cap (Mil)

Shares Outstanding (Mil)

Float (Mil) 		754.753

80.550

79.449 		Current Month (Mil)

Previous Month (Mil)

Short Interest Ratio (Days) 		16.409

14.470

NA


INSTITUTIONAL &
INSIDER OWNERSHIP 		PURCHASES
(Mil) 		SALES
(Mil) 		NET PURCHASES
(Mil) 		PERCENT
OWNED (%) 		PREVIOUS PERCENT
OWNED (%)
Institutions (3 Months)

Insiders (6 Months) 		7.261

0.000 		-8.519

0.324 		-1.258

-0.324 		59.966

1.365 		61.596

NA


GROWTH RATES 1 YEAR 3 YEAR 5 YEAR
Sales %

EPS %

Dividend % 		86.904

NC

NC 		91.078

NC

NC 		35.472

NC

NC


HISTORICAL QUARTERLY RESULTS

REVENUE
( Thousands of USD )
QUARTERS 2006 2007 2008 2009
Q1

Q2

Q3

Q4 		1.267

3.640

4.031

8.307 		1.689

4.098

19.088

29.823 		22.688

25.269

25.477

28.799 		22.232

14.725

4.435

TOTAL 17.245 54.698 102.233
EARNINGS PER SHARE
( USD )
QUARTERS 2006 2007 2008 2009
Q1

Q2

Q3

Q4 		-0.200

-0.120

-0.130

-0.020 		-0.130

-0.110

0.020

0.180 		-0.120

0.060

0.000

-0.100 		-0.100

-0.190

-0.300

TOTAL -0.470 -0.040 -0.160

Copyright © 2010 , Standard & Poor’s, a division of The McGraw-Hill Companies, Inc. Standard & Poor’s including its subsidiary corporations (“S&P”) is a division of The McGraw-Hill Companies, Inc. Reproduction of S&P Compustat in any form is prohibited except with the prior written permission of S&P. Because of the possibility of human or mechanical error by S&P’s sources, S&P or others, S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. S&P GIVES NO EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any indirect, special or consequential damages in connection with subscriber’s or others’ use of S&P Compustat.